Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuralgia | 8 | 2020 | 251 | 1.700 |
Why?
|
| Cyclic N-Oxides | 5 | 2011 | 106 | 0.770 |
Why?
|
| Wnt3A Protein | 1 | 2020 | 29 | 0.770 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2021 | 907 | 0.760 |
Why?
|
| Rats, Sprague-Dawley | 20 | 2020 | 2063 | 0.700 |
Why?
|
| Hyperalgesia | 7 | 2020 | 238 | 0.700 |
Why?
|
| Wnt Proteins | 1 | 2020 | 397 | 0.650 |
Why?
|
| Pain Threshold | 7 | 2009 | 130 | 0.600 |
Why?
|
| Neuroprotective Agents | 2 | 2010 | 215 | 0.590 |
Why?
|
| beta Catenin | 1 | 2020 | 688 | 0.570 |
Why?
|
| Cicatrix | 1 | 2018 | 208 | 0.560 |
Why?
|
| Pain | 7 | 2014 | 1658 | 0.550 |
Why?
|
| Rolipram | 1 | 2015 | 6 | 0.550 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 589 | 0.540 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2015 | 24 | 0.540 |
Why?
|
| Rats | 20 | 2020 | 6086 | 0.520 |
Why?
|
| Flavonoids | 3 | 1999 | 188 | 0.470 |
Why?
|
| Free Radical Scavengers | 3 | 2011 | 80 | 0.450 |
Why?
|
| Capsaicin | 4 | 2009 | 47 | 0.410 |
Why?
|
| Spinal Cord | 4 | 2011 | 690 | 0.400 |
Why?
|
| Behavior, Animal | 5 | 2010 | 709 | 0.370 |
Why?
|
| Reactive Oxygen Species | 4 | 2011 | 987 | 0.350 |
Why?
|
| Biflavonoids | 2 | 1999 | 4 | 0.350 |
Why?
|
| Zymosan | 1 | 2008 | 10 | 0.330 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2010 | 393 | 0.320 |
Why?
|
| Evoked Potentials, Somatosensory | 2 | 2009 | 60 | 0.300 |
Why?
|
| Vibration | 1 | 2006 | 39 | 0.290 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 1999 | 521 | 0.280 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2992 | 0.270 |
Why?
|
| Ganglia, Spinal | 3 | 2020 | 237 | 0.260 |
Why?
|
| Spinal Nerves | 6 | 2011 | 45 | 0.260 |
Why?
|
| Pain Measurement | 7 | 2010 | 953 | 0.260 |
Why?
|
| Arthritis, Experimental | 2 | 2006 | 47 | 0.240 |
Why?
|
| Dermatitis, Atopic | 1 | 2024 | 47 | 0.240 |
Why?
|
| Posterior Horn Cells | 3 | 2010 | 125 | 0.230 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 203 | 0.220 |
Why?
|
| Antineoplastic Agents | 3 | 2015 | 14289 | 0.210 |
Why?
|
| Spinal Cord Injuries | 3 | 2010 | 374 | 0.200 |
Why?
|
| Animals | 23 | 2024 | 59536 | 0.190 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2010 | 259 | 0.190 |
Why?
|
| Dysbiosis | 1 | 2021 | 134 | 0.180 |
Why?
|
| Ginkgo biloba | 1 | 1999 | 16 | 0.180 |
Why?
|
| Plants, Medicinal | 1 | 1999 | 44 | 0.170 |
Why?
|
| Analysis of Variance | 6 | 2011 | 2307 | 0.170 |
Why?
|
| Analgesics | 4 | 2006 | 390 | 0.170 |
Why?
|
| Paclitaxel | 2 | 2020 | 1996 | 0.170 |
Why?
|
| Guanosine Pentaphosphate | 1 | 2018 | 3 | 0.170 |
Why?
|
| Drug Tolerance | 1 | 2018 | 114 | 0.160 |
Why?
|
| Drug Interactions | 3 | 2008 | 553 | 0.150 |
Why?
|
| Plant Extracts | 1 | 1999 | 215 | 0.150 |
Why?
|
| Nitric Oxide | 2 | 2006 | 644 | 0.150 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 7222 | 0.130 |
Why?
|
| Blotting, Western | 2 | 2020 | 3536 | 0.130 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 324 | 0.130 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 1081 | 0.130 |
Why?
|
| Male | 21 | 2020 | 123000 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 3639 | 0.120 |
Why?
|
| Bacteria | 1 | 2018 | 611 | 0.120 |
Why?
|
| Indomethacin | 3 | 1999 | 91 | 0.120 |
Why?
|
| Physical Stimulation | 3 | 2010 | 112 | 0.120 |
Why?
|
| Macrophages | 1 | 1999 | 1304 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 4143 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2011 | 4938 | 0.110 |
Why?
|
| Ligation | 4 | 2007 | 193 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 4320 | 0.090 |
Why?
|
| Acupuncture Points | 2 | 2009 | 18 | 0.090 |
Why?
|
| Mice | 6 | 2024 | 34495 | 0.090 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2009 | 18 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2010 | 151 | 0.090 |
Why?
|
| Receptors, AMPA | 1 | 2010 | 70 | 0.090 |
Why?
|
| Electroacupuncture | 1 | 2009 | 35 | 0.090 |
Why?
|
| Time Factors | 6 | 2011 | 12926 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2011 | 269 | 0.090 |
Why?
|
| Neurons | 3 | 2011 | 2287 | 0.080 |
Why?
|
| Mice, Inbred ICR | 2 | 1999 | 239 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2010 | 218 | 0.080 |
Why?
|
| Peroxidase | 1 | 2008 | 132 | 0.080 |
Why?
|
| Electromyography | 1 | 2008 | 226 | 0.080 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 217 | 0.080 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2006 | 47 | 0.070 |
Why?
|
| Calcium Channels | 1 | 2008 | 197 | 0.070 |
Why?
|
| Moxibustion | 1 | 2006 | 9 | 0.070 |
Why?
|
| Vitamin E | 1 | 2006 | 136 | 0.070 |
Why?
|
| Medulla Oblongata | 1 | 2005 | 45 | 0.070 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 852 | 0.070 |
Why?
|
| Body Weight | 1 | 2010 | 1293 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2004 | 15 | 0.060 |
Why?
|
| Pruritus | 1 | 2024 | 87 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2020 | 11965 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 558 | 0.050 |
Why?
|
| Piperidines | 1 | 2006 | 1035 | 0.050 |
Why?
|
| Humans | 5 | 2021 | 261506 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2015 | 32848 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2009 | 1371 | 0.040 |
Why?
|
| Acetic Acid | 1 | 1999 | 34 | 0.040 |
Why?
|
| Plant Leaves | 1 | 1999 | 61 | 0.040 |
Why?
|
| Croton Oil | 1 | 1998 | 2 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 1999 | 261 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 1999 | 314 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 1998 | 197 | 0.040 |
Why?
|
| Proteins | 1 | 2007 | 1963 | 0.040 |
Why?
|
| Prednisolone | 1 | 1998 | 123 | 0.040 |
Why?
|
| Administration, Topical | 1 | 1998 | 257 | 0.040 |
Why?
|
| Molecular Structure | 1 | 1999 | 515 | 0.040 |
Why?
|
| Hindlimb | 2 | 2009 | 105 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2024 | 1203 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 1999 | 931 | 0.040 |
Why?
|
| Edema | 1 | 1998 | 267 | 0.040 |
Why?
|
| Taurine | 1 | 1996 | 23 | 0.030 |
Why?
|
| Functional Laterality | 2 | 2009 | 316 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1999 | 1764 | 0.030 |
Why?
|
| Stomach Ulcer | 1 | 1996 | 95 | 0.030 |
Why?
|
| Action Potentials | 2 | 2010 | 560 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 4053 | 0.030 |
Why?
|
| Administration, Oral | 1 | 1998 | 1544 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 1999 | 5637 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 1996 | 613 | 0.030 |
Why?
|
| Cell Line | 1 | 1999 | 5114 | 0.030 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2011 | 6 | 0.020 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2011 | 11 | 0.020 |
Why?
|
| Neutrophils | 1 | 1996 | 835 | 0.020 |
Why?
|
| Bicuculline | 1 | 2011 | 55 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1996 | 891 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 2011 | 257 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2010 | 21 | 0.020 |
Why?
|
| Phentolamine | 1 | 2009 | 26 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2011 | 245 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 67 | 0.020 |
Why?
|
| Touch | 1 | 2009 | 71 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 2010 | 186 | 0.020 |
Why?
|
| Narcotic Antagonists | 1 | 2009 | 129 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2009 | 426 | 0.020 |
Why?
|
| Inflammation | 1 | 1998 | 2522 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2007 | 4804 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 15193 | 0.020 |
Why?
|
| Spin Labels | 1 | 2007 | 76 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2008 | 274 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 212 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 43 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2006 | 53 | 0.020 |
Why?
|
| Amidines | 1 | 2005 | 2 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2006 | 123 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2007 | 245 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2005 | 116 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 671 | 0.020 |
Why?
|
| Cell Count | 1 | 2005 | 508 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 702 | 0.020 |
Why?
|
| Antioxidants | 1 | 2007 | 507 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 777 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 657 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 2450 | 0.010 |
Why?
|
| Motor Activity | 1 | 2006 | 693 | 0.010 |
Why?
|
| Proteomics | 1 | 2007 | 1380 | 0.010 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1996 | 18 | 0.010 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1996 | 16 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2005 | 1823 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1996 | 115 | 0.010 |
Why?
|
| Anti-Ulcer Agents | 1 | 1996 | 101 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1996 | 148 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 1996 | 157 | 0.010 |
Why?
|
| Alanine | 1 | 1996 | 240 | 0.010 |
Why?
|
| Quinolones | 1 | 1996 | 160 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 7548 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1996 | 1008 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2005 | 4757 | 0.010 |
Why?
|
| Adult | 1 | 1996 | 77950 | 0.000 |
Why?
|